Cybersecurity Best Practices for Medical Device Design

Cybersecurity in healthcare is about more than protecting data - it’s about protecting patients. The attack surface has never been broader as medical devices become increasingly connected to hospital networks, cloud platforms, and even patients’ homes. Weak security in a medical device doesn’t just expose data; it can delay treatment, disrupt diagnoses, or even cause direct patient harm.

To address these risks, cybersecurity must be built into medical devices from the start - not bolted on later. Below is an authoritative guide to best practices that manufacturers should follow to align with FDA expectations, international standards, and patient safety needs.

Key Takeaways

• Integrate cybersecurity into the Secure Product Development Framework.
• Implement strong authentication and access controls.
• Ensure all data in transit and at rest is encrypted.
• Design for regular, secure software and firmware updates.
• Monitor security events and provide detailed logging.
• Manage third-party risks and maintain an accurate SBOM.

Table of Contents

• Key Takeaways
• 1. Security by Design, Not as an Afterthought
• 2. Authentication and Access Controls
• 3. Encryption and Secure Communication
• 4. Regular Updates and Patch Management
• 5. Monitoring, Logging, and Intrusion Detection
• 6. Testing and Validation
• 7. Supplier and Third-Party Risk Management
• 8. Labeling and User Instructions
• 9. Lifecycle Security and Postmarket Management
• 10. Aligning with Standards and Regulations
• Final Thoughts

Why this matters

Cybersecurity best practices for medical device design are paramount, not merely for regulatory compliance, but for patient safety and organizational integrity. The increasing connectivity of medical devices elevates the risk of security vulnerabilities, which can lead to data breaches, operational disruptions, and direct patient harm. The FDA's Cybersecurity in Medical Devices Final Guidance, dated February 3, 2026, mandates that manufacturers integrate cybersecurity throughout the total product lifecycle. Neglecting these principles can result in regulatory penalties, product recalls, eroded public trust, and severe financial repercussions. Adherence to standards such as IEC 81001-5-1, ISO 27001, and AAMI TIR57 provides a structured approach to managing these risks. Implementing security by design, including threat modeling, secure coding practices, and vulnerability management, is no longer optional but a fundamental requirement. This proactive stance ensures devices function as intended, protecting sensitive health information and safeguarding the well-being of patients who rely on these technologies.

1. Security by Design, Not as an Afterthought

Cybersecurity must be part of the Secure Product Development Framework (SPDF). This means integrating threat modeling, risk assessment, and security requirements into device architecture early. By considering cybersecurity alongside safety and functionality, vulnerabilities can be reduced before products reach the market.

Threat Modeling in Practice

Manufacturers can apply frameworks like STRIDE (Spoofing, Tampering, Repudiation, Information Disclosure, Denial of Service, Elevation of Privilege) or attack trees to identify how devices could be targeted. For example, an insulin pump may be vulnerable to unauthorized wireless access, which could result in dosage manipulation. Documenting these risks early ensures they are addressed before clinical deployment.

2. Authentication and Access Controls

Devices should only be accessible to authorized users, software, and systems. Role-based access control for clinicians and administrators, multi-factor authentication where feasible, and strong credential management are all necessary to reduce the risk of compromise. FDA recalls have shown that weak or hard-coded credentials are a recurring problem, making it critical to address this issue early.

3. Encryption and Secure Communication

Patient data - whether stored on the device or transmitted wirelessly - must be encrypted. Secure communication protocols such as TLS or DTLS protect integrity and confidentiality. Without these measures, devices remain exposed to interception and tampering. A 2019 FDA advisory warned about vulnerabilities in certain cardiac implants that lacked strong encryption, leaving patient data and device commands at risk. Encryption is now an essential expectation.

4. Regular Updates and Patch Management

Cyber threats evolve faster than device lifecycles. Manufacturers must design devices to support secure software and firmware updates. This includes digital signing of update packages, secure delivery mechanisms, and verification processes to prevent tampering. Without patching, devices become liabilities. Past advisories for insulin pumps and implantable devices highlight the importance of building update mechanisms into device design.

5. Monitoring, Logging, and Intrusion Detection

Devices should log security events and integrate with hospital security operations centers. Logs must be tamper-resistant and provide forensic value in the event of an incident. At the network level, anomaly detection helps identify suspicious behavior across connected fleets of devices. Healthcare organizations increasingly deploy network-based intrusion detection systems that monitor device behavior. Devices that provide visibility and structured logging reduce time to detection and response.

6. Testing and Validation

Cybersecurity is not complete without rigorous validation. Manufacturers should conduct penetration testing against real-world attack scenarios, perform static and dynamic code analysis to identify flaws, and use vulnerability scanning tied to an SBOM (Software Bill of Materials) to track risks in third-party components. FDA has emphasized that SBOMs are essential for transparency and postmarket vulnerability management. Without them, organizations cannot assess exposure to emerging threats like Log4j or OpenSSL flaws.

7. Supplier and Third-Party Risk Management

See also: How to Choose the Best Medical Device Cybersecurity Company, Best Practices for Medical Device Cybersecurity, and Medical Device Security Testing: The Complete Taxonomy.

Most medical devices rely on third-party components, from operating systems to cloud platforms. Each dependency introduces potential vulnerabilities. Manufacturers must vet suppliers for security maturity, require SBOMs from vendors, and conduct risk assessments of third-party libraries and services. The URGENT/11 and SweynTooth vulnerabilities demonstrated how flaws in common third-party components can cascade across entire categories of devices.

8. Labeling and User Instructions

FDA guidance stresses the importance of clear labeling that provides configuration instructions for secure deployment, update and patching procedures, and contact information for reporting vulnerabilities. This ensures healthcare providers can maintain device security throughout its lifecycle.

9. Lifecycle Security and Postmarket Management

Cybersecurity doesn’t end at FDA clearance. Continuous monitoring, coordinated vulnerability disclosure programs, and postmarket support plans are essential. FDA expects manufacturers to manage security across the Total Product Lifecycle, including patch development and deployment, ongoing threat monitoring, and transparency with customers and regulators.

10. Aligning with Standards and Regulations

While FDA guidance provides U.S.-specific direction, manufacturers should align with global standards such as ISO 27001 for information security management, ISO 14971 for risk management with a focus on patient safety, IEC 81001-5-1 for health software safety, and the NIST Cybersecurity Framework for overall maturity. These frameworks help create a harmonized approach that meets both domestic and international regulatory expectations.

Final Thoughts

Cybersecurity in medical device design is not optional; it’s a patient safety requirement. Manufacturers who embed cybersecurity into their SPDF meet FDA and international expectations and build trust with providers and patients.

At Blue Goat Cyber, we help device makers implement these best practices through threat modeling, penetration testing, SBOM analysis, and compliance support - ensuring devices are secure by design, compliant by necessity, and safe for patients.

How Blue Goat approaches this

Blue Goat Cyber assists medical device manufacturers in establishing and refining their cybersecurity practices from conception through postmarket surveillance. Our methodology emphasizes embedding security into every stage of the Secure Product Development Framework (SPDF) to meet and exceed regulatory expectations. We provide tailored services, including threat modeling, architectural review, and penetration testing, ensuring devices are resilient against evolving threats. Our team brings credentials such as CISSP and OSCP, alongside experience from ex-military red teams, to identify and mitigate vulnerabilities effectively. We streamline your compliance journey, preparing submissions that satisfy the FDA's Cybersecurity in Medical Devices Final Guidance and other international standards. We stand by our work: If the FDA raises cybersecurity deficiencies after our submission, we resolve them at no additional cost. Explore our tailored solutions at https://www.bluegoatcyber.com/services/fda-premarket-cybersecurity-services.

FAQ

What is security by design for medical devices?

Security by design involves integrating cybersecurity considerations, such as threat modeling and risk assessment, from the initial stages of medical device development. This ensures vulnerabilities are addressed proactively rather than as an afterthought, aligning with FDA expectations.

How does the FDA guidance impact medical device cybersecurity?

The FDA's February 3, 2026 final guidance mandates that manufacturers submit plans for addressing cybersecurity risks throughout the total product lifecycle. This includes detailed documentation of security controls, design considerations, and postmarket management plans for premarket device submissions.

Why are SBOMs important for medical device cybersecurity?

Software Bill of Materials (SBOMs) matter for transparency and postmarket vulnerability management. They enable manufacturers and healthcare providers to identify and assess exposure to known vulnerabilities within third-party components, as emphasized by the FDA.

Does encryption apply to all medical device data?

Yes, encryption is an essential expectation for all medical device data. This includes patient data stored on the device and any data transmitted wirelessly, using secure protocols like TLS or DTLS, to protect confidentiality and integrity.

What postmarket responsibilities do manufacturers have for cybersecurity?

Manufacturers have ongoing postmarket responsibilities, including continuous monitoring, operating coordinated vulnerability disclosure programs, and developing security update plans. The FDA expects active management of security across the entire product lifecycle, even after clearance.

Can medical devices be updated securely?

Medical devices must be designed to support secure software and firmware updates. This requires capabilities such as digital signing of update packages, secure delivery mechanisms, and verification processes to prevent tampering and ensure the integrity of the updates.

Related: The Rising Tide of Cyber Threats in Medical Devices: Understanding the Risks

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.